Leo Verhagen Metman, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Christopher Randolph, PhD, ABPP-CN, Chief Scientific Officer, WCG MedAvante-ProPhase. Dr. Verhagen is a professor of neurology at Rush University Medical Center in Chicago.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies
Basket Clinical Trial Designs The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct
Driving High Performance - Shortening study start-up and optimizing revenue generation
Placebo Response Reduction
WCG has developed and validated the industry-leading Placebo Response Reduction training program.